United States · FDA National Drug Code directory
hydromorphone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72865-170_55fb6272-5677-43cf-b92d-5a6a6f484b6e
- Product NDC
- 72865-170
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- hydromorphone hydrochloride
- Labeler
- XLCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200924
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 16 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-170-01) · 72865-170-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →